Literature DB >> 1331233

Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor [corrected].

G H Wong1, L A Tartaglia, M S Lee, D V Goeddel.   

Abstract

Agonist antibodies (Ab) to the two TNF receptors, TNF-R1 (55 kDa) and TNF-R2 (75 kDa), have been shown to signal many of the distinct functions induced by TNF-alpha. We have found that anti-TNF-R1, but not anti-TNF-R2, Ab trigger antiviral activity in human hepatoma Hep-G2 cells and enhance the antiviral activity of IFN-gamma in human lung fibroblast A549 cells. Likewise, anti-human-TNF-R1 Ab had antiviral enhancing activity on murine L929 cells engineered to express human TNF-R1. However, L929 cells that express human TNF-R1 lacking most of the intracellular domain fail to respond to anti-human-TNF-R1 Ab. This demonstrates that the intracellular domain of TNF-R1 is necessary to generate antiviral activity. TNF-R1 but not TNF-R2 also signals killing of virus-infected cells by TNF-alpha. Thus, all the known antiviral activities of TNF-alpha are mediated through TNF-R1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331233

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Lipopolysaccharide-stimulated osteoclastogenesis is mediated by tumor necrosis factor via its P55 receptor.

Authors:  Y Abu-Amer; F P Ross; J Edwards; S L Teitelbaum
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

2.  Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1.

Authors:  F Samad; K T Uysal; S M Wiesbrock; M Pandey; G S Hotamisligil; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

3.  Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor.

Authors:  G Herbein; L J Montaner; S Gordon
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

4.  Distinct pathways for tumor necrosis factor alpha and ceramides in human cytomegalovirus infection.

Authors:  J Allan-Yorke; M Record; C de Préval; C Davrinche; J L Davignon
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

5.  Peptide vaccination of mice immune to LCMV or vaccinia virus causes serious CD8 T cell-mediated, TNF-dependent immunopathology.

Authors:  Fei Liu; Ralph Feuer; Daniel E Hassett; J Lindsay Whitton
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

6.  Cytokine (IL-8, IL-6, TNF-alpha) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection.

Authors:  R Arnold; B König; H Galatti; H Werchau; W König
Journal:  Immunology       Date:  1995-07       Impact factor: 7.397

7.  Analysis of p60 and p80 tumor necrosis factor-alpha receptor messenger RNA and protein in human placentas.

Authors:  K K Yelavarthi; J S Hunt
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

8.  Immunological markers of childhood fevers in an area of intense and perennial malaria transmission.

Authors:  N Hurt; M Thein; T Smith; G Bordmann; H Gallati; N Drees; M Tanner; N Weiss
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

9.  Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus.

Authors:  T Rothoeft; K Fischer; S Zawatzki; V Schulz; U Schauer; C Körner Rettberg
Journal:  Clin Exp Immunol       Date:  2007-09-24       Impact factor: 4.330

10.  Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.

Authors:  K C Sheehan; J K Pinckard; C D Arthur; L P Dehner; D V Goeddel; R D Schreiber
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.